Searched for
DNA VACCINE
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Zydus Cadila starts supply of Covid 19 vaccine to govtThe Ahmedabad-based drugmaker has also entered into a definitive agreement with Shilpa Medicare Ltd, a contract manufacturing organisation,...
- Production ramp up delayed Zydus Cadila’s vaccine launch, roll out likely soonZydus had received an order from the government to supply 10 million doses of ZyCoV-D, the world's first plasmid DNA vaccine, at ₹265 per d...
- Cadila's Covid vax to be introduced in 7 states firstThe Indian government will initially introduce Cadila Healthcare's Covid-19 vaccine ZyCoV-D in seven states, including Maharashtra and West...
- NTAGI to soon come out with guidelines on vaccinating kidsZyCoV-D is the first DNA plasmid vaccine in the world , developed indigenously by the company against the Covid-19 virus.
- India first to develop DNA vaccine, can be administered to 12 and above: PM Narendra Modi"India, which lives on Sewa Paramo Dharma (service is the main duty), is engaged in vaccination development and manufacturing despite limit...
- PM Narendra Modi asks Covid-19 vaccine makers to make shots in IndiaModi also said that India has developed the world's first DNA vaccine for Covid-19. "I would like to inform the UNGA that India has develop...
- Talks on to make Zydus Cadila's COVID-19 DNA vaccine part of inoculation programme: GovtZydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D received the Emergency Use Authorisation from the Drugs Controll...
- Zydus jab likely to cost more than Covishield, pricing to be out soonZydus Cadila's Covid vaccine, which is likely to be launched next month, may cost more than Covishield but will be comparable with those al...
- PM Modi lauds India's scientists for developing Zydus Cadila's DNA-based Covid vaccine ZyCoV-DThe Prime Minister tweeted saying that India is resolutely fighting the Covid battle and the approval of the world's first DNA-based vaccin...
- Can the Pfizer or Moderna mRNA vaccines affect my genetic code?Both the Pfizer and Moderna vaccines are mRNA vaccines, which contain tiny fragments of the genetic material known as “messenger ribonuclei...
- DNA-based coronavirus vaccine: What is it and how does it work?While still in early stages, this technology has been developed rapidly by experts and if approved, the vaccine developed by India's Zydus ...
- Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next weekPharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the ...
- New DNA vaccine for COVID-19 effective in mice, hamsters: StudySome currently available COVID-19 vaccines rely on messenger RNA or mRNA strands to teach the human immune system to recognise the SARS-CoV...
- Zydus Cadila to apply for Phase-3 trials in December, hopes to launch vaccine by MarchThe Ahmedabad-based drug maker will submit the results of its phase-2 trials next week, which "will ascertain the safety, dose and efficacy...
- Zydus Cadila begins human trials of its COVID-19 vaccine, aims for an early 2021 launchThe company said in the preclinical stage the vaccine was found to be safe, immunogenic and well-tolerated. It was also able to produce neu...
- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- Ebola vaccine safe for use in Africa, say scientists from NIAIDScientists from the NIAID have developed two experimental DNA vaccines that code for Ebola virus proteins from the Zaire and Sudan strains.
- New DNA 'reverse' vaccine holds promise for diabetesA clinical trial of a DNA 'reverse' vaccine designed to combat type-1 diabetes, has delivered initially promising results, scientists say.
Load More
